MedTrace Logo

Assessment of the Remineralization Efficacy of Vitamin D in the Treatment of MIH and Its Role in Improving Oral Hygiene and Gingival Health. In Situ Randomized Double-Blind Placebo CT

NCT06515548 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-03-12

No results posted yet for this study

Summary

In child patients with molar incisor hypo mineralization, Will Vitamin D mouth wash offer more success for patients with MIH as regards better MIH TNI index, decrease plaque accumulation, more gingival health and less bleeding on probing differentiated from placebo mouthwash?

Conditions

  • Molar Incisor Hypomineralization

Interventions

DRUG

Vitamin D3 mouth wash

topical vitamin D oral mouth wash as every 10ml of the solution contains 3000 IU

Sponsors & Collaborators

  • MTI University

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • Parryhan M Abdelsamie, PhD · MTI University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-30
Primary Completion
2025-02-01
Completion
2025-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06515548 on ClinicalTrials.gov